BioAtla, Inc.
BCAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $49 | $111 | $216 | $245 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $5 | $5 | $2 |
| Total Curr. Assets | $51 | $116 | $220 | $247 |
| Property Plant & Equip (Net) | $1 | $3 | $5 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $3 | $5 | $7 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $52 | $120 | $226 | $254 |
| Liabilities | – | – | – | – |
| Payables | $2 | $4 | $4 | $1 |
| Short-Term Debt | $1 | $2 | $2 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $12 | $23 | $17 | $17 |
| Total Curr. Liab. | $15 | $28 | $23 | $20 |
| LT Debt | $0 | $1 | $2 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $24 | $20 | $20 | $20 |
| Total NC Liab. | $24 | $21 | $22 | $24 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $4 | $5 |
| Total Liabilities | $38 | $49 | $45 | $44 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$486 | -$416 | -$293 | -$186 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $500 | $487 | $473 | $397 |
| Total Equity | $14 | $71 | $180 | $211 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $52 | $120 | $226 | $254 |
| Net Debt | -$48 | -$109 | -$212 | -$240 |